MedTrace Logo

Pain Control After Minimally Invasive Coronary Artery Bypass Grafting

NCT01770236 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2016-12-21

No results posted yet for this study

Summary

The purpose of this study is to compare postoperative pain control after minimally invasive coronary artery bypass grafting for patients who receive an intercostal block (an anesthetic medicine injected in an area under the ribs) in the operating room and IV acetaminophen (Tylenol) to those who receive an intercostal block and On-Q pain pump catheter (a balloon pump attached to 2 small tubes near your procedure site that automatically delivers pain medicine).

Conditions

  • Postoperative Pain
  • Medication Side Effects
  • Narcotic Requirement

Interventions

DRUG

IV acetaminophen

Patients randomized to the IV acetaminophen group will receive IV acetaminophen (1000 mg every 6 hours for adults and weight-based for any patient under 50 kg)instead of an On-Q pain pump catheter.

Sponsors & Collaborators

  • Gundersen Lutheran Medical Foundation

    lead OTHER

Principal Investigators

  • Prem Rabindra, MD · Gundersen Health System

  • Kym Culp, MD · Gundersen Health System

  • Korey Zellner, PA-C · Gundersen Health System

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01770236 on ClinicalTrials.gov